Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications by Elin Ødegaard

10 publications found

Original articles

Elgaaen BV, Olstad OK, Sandvik L, Odegaard E, Sauer T, Staff AC, Gautvik KM (2012)
ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival
PLoS One, 7 (9), e46317
DOI 10.1371/journal.pone.0046317, PubMed 23029477

Bunkholt Elstrand M, Dong HP, Ødegaard E, Holth A, Elloul S, Reich R, Tropé CG, Davidson B (2010)
Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma
Hum Pathol, 41 (6), 794-804
DOI 10.1016/j.humpath.2009.09.017, PubMed 20153512

Ødegaard E, Davidson B, Engh V, Onsrud M, Staff AC (2008)
Assessment of endoglin and calprotectin as potential biomarkers in ovarian carcinoma and borderline tumors of the ovary
Am J Obstet Gynecol, 199 (5), 533.e1-8
DOI 10.1016/j.ajog.2008.04.004, PubMed 18533117

Ødegaard E, Davidson B, Elgaaen BV, Fagerhol MK, Engh V, Onsrud M, Staff AC (2008)
Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary
Am J Obstet Gynecol, 198 (4), 418.e1-7
DOI 10.1016/j.ajog.2007.10.792, PubMed 18241816

Ødegaard E, Staff AC, Langebrekke A, Engh V, Onsrud M (2007)
Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy
Acta Obstet Gynecol Scand, 86 (5), 620-6
DOI 10.1080/00016340701286934, PubMed 17464594

Ødegaard E, Staff AC, Abeler VM, Kopolovic J, Onsrud M, Lazarovici P, Davidson B (2006)
The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma
Hum Pathol, 38 (1), 140-6
DOI 10.1016/j.humpath.2006.06.027, PubMed 16996570

Karlsen JT, Andersen J, Birkely LS, Odegard E (2005)
What characterizes successful it projects
Int. J. Inf. Technol. Decis. Mak., 4 (4), 525-540
DOI 10.1142/S0219622005001738

Ødegaard E, Staff AC, Kaern J, Flørenes VA, Kopolovic J, Tropé CG, Abeler VM, Reich R, Davidson B (2005)
The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma
Gynecol Oncol, 100 (3), 462-8
DOI 10.1016/j.ygyno.2005.09.022, PubMed 16216317

Ødegaard E, Qvigstad E, Kløw NE (2003)
[Intractable postpartum haemorrhage treated with selective arterial embolization]
Tidsskr Nor Laegeforen, 123 (19), 2715-6
PubMed 14600743

Theses

Ødegaard E (2008)
Ovarian carcinomas and borderline ovarian tumors: molecular markers and operative treatment
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 623, 1 b. (flere pag.)
BIBSYS 080696023, ISBN 978-82-8072-902-6

0.12s